[1]
G. Ciprandi and M. Naso, “Tablet allergen immunotherapy: the anaphylaxis issue”, Allergol Immunopathol, vol. 52, no. 3, pp. 73–77, May 2024, doi: 10.15586/aei.v52i3.990.